Colorectal squamous cell carcinoma: a rare tumor with poor prognosis

被引:33
|
作者
Ozuner, Gokhan [1 ]
Aytac, Erman [1 ]
Gorgun, Emre [1 ]
Bennett, Ana [2 ]
机构
[1] Inst Digest Dis, Dept Colorectal Surg, Cleveland, OH 44195 USA
[2] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44106 USA
关键词
Squamous cell carcinoma; Colorectal; Survival; Treatment; ADENOSQUAMOUS CARCINOMA; UPPER RECTUM; COLON; ANUS; CHEMOTHERAPY; CANCER;
D O I
10.1007/s00384-014-2058-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose Primary squamous cell carcinomas of the colon and rectum are extremely rare, with an incidence of less than 1 % of colorectal malignancies. Our aim in this study was to evaluate patient characteristics, treatment strategy, and postoperative follow-up of patients with colorectal squamous cell carcinoma. Methods We reviewed our prospectively maintained colorectal cancer database for all patients who were diagnosed with colorectal squamous cell carcinoma between January 1990 and April 2009. Results Out of 5149 patients with colorectal malignancy, 11 patients (0.2 %) met the study criteria. Median age at the time of diagnosis was 64. Median BMI was 28 kg/m(2). The tumors were localized in the rectum (n = 8), right colon (n = 2), and sigmoid colon (n = 1). The pathologic stages of these tumors were I (n = 1), II (n = 4), III (n = 3), and IV (n = 3). Operations performed were abdominoperineal resection (n = 4), right colectomy (n = 2), total colectomy (n = 1), low anterior resection (n = 1), local excision (n = 1), sigmoidectomy (n=1) and end colostomy creation (n = 1). One patient received intraoperative radiotherapy. Postoperative chemotherapy was given to eight patients, and three patients received postoperative radiation therapy. Median follow-up after diagnosis was 42 months (12-96). Three patients developed recurrence after potentially curative surgery. Five patients died from metastatic disease during follow-up. Conclusion Squamous colorectal cancer can be detected in any part of the colon, generally presents at a later stage, and is associated with a poor prognosis. Surgery is the mainstay of treatment. Various adjuvant chemoradiation treatments appear not to influence the outcome. Further cases need to be analyzed in order to find more effective treatment regimens.
引用
收藏
页码:127 / 130
页数:4
相关论文
共 50 条
  • [21] FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma
    Yang, Yanru
    Zhao, Yun
    Sun, Guorui
    Zuo, Saijie
    Chai, Jia
    Xu, Tianqi
    Liu, Jin
    Li, Lingfei
    Song, Junyang
    Qian, Shoubin
    Kang, Yulin
    Sui, Fang
    Li, Mingyang
    Jia, Qingge
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [22] Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT
    Na, Sijia
    Cui, Hao
    Guo, Zhichen
    Liang, Xiang
    Sakran, Karim Ahmed
    Guo, Xiaomei
    Li, Xingqiang
    Xie, Linyang
    Zhu, Yifei
    Qi, Hong
    Tu, Junbo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma
    Nakade, Hiroshi
    Migita, Kazuhiro
    Matsumoto, Sohei
    Wakatsuki, Kohei
    Kunishige, Tomohiro
    Miyao, Shintaro
    Sho, Masayuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 446 - 455
  • [24] Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
    Yu, Xinshuang
    Zhang, Jiandong
    Zhong, Hua
    Liu, Fengjun
    Liang, Ning
    Wang, Yao
    Meng, Xiangjiao
    Du, Juan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2016, 13 (12): : 963 - 969
  • [25] TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma
    Di, Shouyin
    Li, Mingyang
    Ma, Zhiqiang
    Guo, Kai
    Li, Xiaofei
    Yan, Xiaolong
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
  • [26] lncRNA XIST promotes aggressive tumor phenotype and is associated with poor prognosis in esophageal squamous cell carcinoma
    Yi, Shengzhong
    Zhang, Wei
    Zhou, Qianyi
    Cheng, Guirong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8317 - 8323
  • [27] Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma
    Wang, Cheng
    Huang, Hongzhang
    Huang, Zhiquan
    Wang, Anxun
    Chen, Xiaohua
    Huang, Lei
    Zhou, Xiaofeng
    Liu, Xiqiang
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (07) : 545 - 551
  • [28] XBP1 promotes tumor invasion and is associated with poor prognosis in oral squamous cell carcinoma
    Sun, Yanan
    Jiang, Fangyan
    Pan, Yuemei
    Chen, Xinming
    Chen, Jirong
    Wang, Yu
    Zheng, Xueqing
    Zhang, Jiali
    ONCOLOGY REPORTS, 2018, 40 (02) : 988 - 998
  • [29] Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma
    Hiroshi Nakade
    Kazuhiro Migita
    Sohei Matsumoto
    Kohei Wakatsuki
    Tomohiro Kunishige
    Shintaro Miyao
    Masayuki Sho
    International Journal of Clinical Oncology, 2020, 25 : 446 - 455
  • [30] Overexpression of periostin is significantly correlated to the tumor angiogenesis and poor prognosis in patients with esophageal squamous cell carcinoma
    Wang, Wei
    Sun, Qi-Kai
    He, Yi-Fu
    Ma, Dong-Chun
    Xie, Ming-Ran
    Ji, Chu-Shu
    Hu, Bing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (02): : 593 - 601